88 related articles for article (PubMed ID: 7595702)
1. All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship.
Agadir A; Cornic M; Lefebvre P; Gourmel B; Jérôme M; Degos L; Fenaux P; Chomienne C
J Clin Oncol; 1995 Oct; 13(10):2517-23. PubMed ID: 7595702
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case.
Akman BT; Arıca D; Koca E; Karakuş S
J Oncol Pharm Pract; 2024 Apr; 30(3):605-609. PubMed ID: 37981866
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia.
Magliulo D; Simoni M; Caserta C; Fracassi C; Belluschi S; Giannetti K; Pini R; Zapparoli E; Beretta S; Uggè M; Draghi E; Rossari F; Coltella N; Tresoldi C; Morelli MJ; Di Micco R; Gentner B; Vago L; Bernardi R
EMBO Mol Med; 2023 Nov; 15(11):e17810. PubMed ID: 37807875
[TBL] [Abstract][Full Text] [Related]
4. Cellular and micro-environmental responses influencing the antitumor activity of all-trans retinoic acid in breast cancer.
Caricasulo MA; Zanetti A; Terao M; Garattini E; Paroni G
Cell Commun Signal; 2024 Feb; 22(1):127. PubMed ID: 38360674
[TBL] [Abstract][Full Text] [Related]
5. [JMJD3 Exerts Oncorepressor Activity in Acute Promyelocytic Leukemia by Promoting PU.1 Expression].
-Xi Wang M; -He Yu S; Xiao M; Chen J
Mol Biol (Mosk); 2023; 57(4):665-667. PubMed ID: 37528785
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation.
Brigger D; Torbett BE; Chen J; Fey MF; Tschan MP
Biochem Biophys Res Commun; 2013 Aug; 438(2):283-8. PubMed ID: 23891751
[TBL] [Abstract][Full Text] [Related]
7. Physiologically Based Pharmacokinetic Model of All-
Jing J; Nelson C; Paik J; Shirasaka Y; Amory JK; Isoherranen N
J Pharmacol Exp Ther; 2017 May; 361(2):246-258. PubMed ID: 28275201
[TBL] [Abstract][Full Text] [Related]
8. miR-125b-5p-MAPK1-C/EBPα feedback loop regulates all-trans retinoic acid resistance in acute promyelocytic leukemia.
Jiang W; Hu Y; Wang X; Zhang Q; Guo X; Cheng S; Chen L; Ying J; Zhang L; Jiang B
Gene; 2023 Dec; 889():147806. PubMed ID: 37717613
[TBL] [Abstract][Full Text] [Related]
9. Mechanical phenotyping reveals unique biomechanical responses in retinoic acid-resistant acute promyelocytic leukemia.
Li B; Maslan A; Kitayama SE; Pierce C; Streets AM; Sohn LL
iScience; 2022 Feb; 25(2):103772. PubMed ID: 35141508
[TBL] [Abstract][Full Text] [Related]
10. The influence of hospital volume and physician volume on early mortality in acute promyelocytic leukemia patients.
Wu CY; Yeh CM; Tsai CK; Liu CJ
Ann Hematol; 2024 May; 103(5):1577-1586. PubMed ID: 38532122
[TBL] [Abstract][Full Text] [Related]
11. 20(S)-ginsenoside Rh2 ameliorates ATRA resistance in APL by modulating lactylation-driven METTL3.
Cheng S; Chen L; Ying J; Wang Y; Jiang W; Zhang Q; Zhang H; Wang J; Wang C; Wu H; Ye J; Zhang L
J Ginseng Res; 2024 May; 48(3):298-309. PubMed ID: 38707638
[TBL] [Abstract][Full Text] [Related]
12. Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration.
Nauffal M; Werner L; Ni J; Stone RM; DeAngelo DJ; McDonnell AM
Leuk Res Rep; 2019; 12():100189. PubMed ID: 31867205
[TBL] [Abstract][Full Text] [Related]
13. The CDK4/6 inhibitor Palbociclib synergizes with ATRA to induce differentiation in AML.
Hu L; Li Q; Wang J; Wang H; Ren X; Huang K; Wang Y; Liang X; Pu L; Xiong S; Zhai Z
Mol Cancer Ther; 2024 Mar; ():. PubMed ID: 38507743
[TBL] [Abstract][Full Text] [Related]
14. Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL.
Ghiaur A; Ghiaur G
Haematologica; 2023 Nov; 108(11):2886-2888. PubMed ID: 37288506
[No Abstract] [Full Text] [Related]
15. Differences in the lipoprotein distribution of free and liposome-associated all-trans-retinoic acid in human, dog, and rat plasma are due to variations in lipoprotein lipid and protein content.
Wasan KM; Ramaswamy M; Ng SP; Wong W; Parrott SC; Ojwang JO; Wallace T; Cossum PA
Antimicrob Agents Chemother; 1998 Jul; 42(7):1646-53. PubMed ID: 9660998
[TBL] [Abstract][Full Text] [Related]
16. Differentiation Syndrome in Acute Leukemia: APL and Beyond.
Woods AC; Norsworthy KJ
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835461
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.
Adamson PC; Bailey J; Pluda J; Poplack DG; Bauza S; Murphy RF; Yarchoan R; Balis FM
J Clin Oncol; 1995 May; 13(5):1238-41. PubMed ID: 7738627
[TBL] [Abstract][Full Text] [Related]
18. All-Trans Retinoic Acid Effect on
Pistoia ES; Cosio T; Campione E; Pica F; Volpe A; Marino D; Di Francesco P; Monari C; Fontana C; Favaro M; Zampini P; Orlandi A; Gaziano R
J Fungi (Basel); 2022 Oct; 8(10):. PubMed ID: 36294614
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours.
Pili R; Salumbides B; Zhao M; Altiok S; Qian D; Zwiebel J; Carducci MA; Rudek MA
Br J Cancer; 2012 Jan; 106(1):77-84. PubMed ID: 22134508
[TBL] [Abstract][Full Text] [Related]
20. Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week Off.
Regazzi MB; Russo D; Iacona I; Sacchi S; Visani G; Lazzarino M; Avvisati G; Pelicci PG; Dastoli G; Grandi C; Spreafico S; Grattoni R; Galieni P; Rupoli S; Maiolo AM; Guerra E; Liberati AM
Clin Drug Investig; 1998; 16(1):25-33. PubMed ID: 18370515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
